计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| D302525-5mg |
5mg |
现货 ![]() |
| |
| D302525-25mg |
25mg |
现货 ![]() |
| |
| D302525-100mg |
100mg |
现货 ![]() |
| |
| D302525-250mg |
250mg |
现货 ![]() |
| |
| D302525-500mg |
500mg |
现货 ![]() |
| |
| D302525-1g |
1g |
现货 ![]() |
| |
| D302525-5g |
5g |
现货 ![]() |
|
| 别名 | 去铁胺 甲磺酸盐 | 去铁胺甲磺酸酯 | 甲磺酸去铁敏 | 甲磺酸除铁灵 |
|---|---|
| 英文别名 | Deferoxamine mesilate | Deferoxamine mesylate | Deferoxamine methanesulfonate | Desferrioxamine B mesylate |
| 规格或纯度 | ≥98% |
| 英文名称 | Deferoxamine mesylate |
| 生化机理 | 铁螯合剂。血脑屏障通透。显示许多生物学作用,例如免疫调节,抑制炎症和动脉粥样硬化以及减少神经元死亡。 |
| 储存温度 | -20°C储存,充氩 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 螯合剂 |
| 作用机制 | 铁螯合剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 纯度 | ≥98% |
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机酸及其衍生物 |
| 类(Class) | 有机磺酸及其衍生物 |
| 亚类(Subclass) | 有机磺酸及其衍生物 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 有机磺酸 |
| 其他上位类(Alternative Parents) | 磺酰基 甲磺酸盐 烷磺酸 乙酰异羟肟酸 乙酰胺 氨基酸及其衍生物 炔丙基型1,3-偶极有机化合物 羧酰亚胺酸 有机光子化合物 有机氧化物 单烷基胺 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 暂无 |
| 取代基(Substituents) | Methanesulfonate - Organosulfonic acid - Sulfonyl - Acetohydroxamic acid - Acetamide - Alkanesulfonic acid - Amino acid or derivatives - Hydroxamic acid - Carboximidic acid - Carboximidic acid derivative - Carboxylic acid derivative - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Organosulfur compound - Organooxygen compound - Organonitrogen compound - Primary aliphatic amine - Organopnictogen compound - Organic oxygen compound - Organic nitrogen compound - Amine - Primary amine - Organic oxide - Hydrocarbon derivative - Carbonyl group - Aliphatic acyclic compound |
| 描述(Description) | 该化合物属于有机化合物中称为有机磺酸的类别。这类化合物含有磺酸基团,其通式为RS(=O)₂OH(R非氢原子)。 |
| 外部描述符(External Descriptors) | methanesulfonate salt |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504753887 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid |
| INCHI | 1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4) |
| InChi Key | IDDIJAWJANBQLJ-UHFFFAOYSA-N |
| Smiles | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
| Isomeric SMILES | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
| 分子量 | 656.79 |
| Reaxy-Rn | 4122177 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=4122177&ln= |
| 敏感性 | 对湿度敏感、对热敏感、对空气敏感 |
|---|---|
| 分子量 | 656.800 g/mol |
| XLogP3 | |
| 氢键供体数Hydrogen Bond Donor Count | 7 |
| 氢键受体数Hydrogen Bond Acceptor Count | 12 |
| 可旋转键计数Rotatable Bond Count | 23 |
| 精确质量Exact Mass | 656.341 Da |
| 单同位素质量Monoisotopic Mass | 656.341 Da |
| 拓扑极表面积Topological Polar Surface Area | 269.000 Ų |
| 重原子数Heavy Atom Count | 44 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 832.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 2 |
| 象形图 | GHS08, GHS07 |
|---|---|
| 信号词 | Danger |
| 危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 H341: 怀疑引起遗传缺陷 H317: 可能引起皮肤过敏反应 H334: 吸入可能引起过敏或哮喘病症状或呼吸困难 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染:用水充分清洗。 P321: 特殊处理(请参阅此标签上的...)。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P284: 如果通风不良,请佩戴呼吸防护装置。 P281: 根据需要使用个人防护设备。 P271: 仅在室外或通风良好的地方使用。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P403+P233: 存放在通风良好的地方。保持容器密闭。 P272: 被污染的工作服不允许离开工作场所 P333+P313: 如发生皮肤刺激或皮疹:求医/就诊。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P203: 使用前,获取、阅读并遵守所有安全说明。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P318: 如果暴露或担心,请就医。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 P342+P316: 如果出现呼吸道症状:立即寻求急救。 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 25-05-21 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-06-29 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 24-03-07 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-10-21 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-06-12 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 23-02-01 | D302525 | |
| 分析证书 | 22-08-01 | D302525 | |
| 分析证书 | 22-08-01 | D302525 | |
| 分析证书 | 22-08-01 | D302525 | |
| 分析证书 | 22-08-01 | D302525 | |
| 分析证书 | 22-08-01 | D302525 | |
| 分析证书 | 22-08-01 | D302525 |
¥382.90
| 1. Furukawa T et al.. (2017) Chronic diazepam administration increases the expression of Lcn2 in the CNS.. Pharmacol Res Perspect, 5 (e00283). [PMID:28596835] |
| 2. Henning Y et al.. (2022) Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction.. Cell Death Dis, 13 (7): (662). [PMID:35906211] |
| 3. Rakshit J et al.. (2020) Iron chelator Deferoxamine protects human neuroblastoma cell line SH-SY5Y from 6-Hydroxydopamine-induced apoptosis and autophagy dysfunction.. J Trace Elem Med Biol, 57 (126406). [PMID:31570251] |
| 4. Sias SR & Ingraham JL. (1979) Isolation and analysis of mutants of Pseudomonas aeruginosa unable to assimilate nitrate.. Arch Microbiol, 122 (3): (263-70). [PMID:120727] |
| 5. Yao Q et al.. (2018) Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.. J Control Release, 279 (69-78). [PMID:29649529] |
| 6. Tadokoro T et al.. (2020) Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.. JCI Insight, 5 (9): [PMID:32376803] |
| 7. You JH et al.. (2021) PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.. J Exp Clin Cancer Res, 40 (350). [PMID:34749765] |
| 8. Fu C et al.. (2020) The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1a in liver cancer cells.. J Biol Chem, 295 (20): (7060-7074). [PMID:32277050] |
| 9. Nishimura K et al.. (2018) Type 3 iodothyronine deiodinase is expressed in human induced pluripotent stem cell derived cardiomyocytes.. Life Sci, 203 (276-281). [PMID:29684447] |
| 10. Sugiyama A et al.. (2020) xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma.. Oncol Lett, 20 (3): (2689-2700). [PMID:32782585] |
| 11. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] [10.1016/j.ejmech.2023.116110] |
| 12. Weimin Yin, Jiao Chang, Jiuyuan Sun, Yuge Zhao, Shiyu Chen, Hui Zhi, Jie Zang, Tingting Zhang, Yongyong Li, Haiqing Dong. (2024) Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy. Applied Materials Today, 36 (102047). [10.1016/j.apmt.2023.102047] |
| 13. Wang Shengmei, Guo Qiuyan, Xu Rubing, Lin Peng, Deng Guoyan, Xia Xinhua. (2023) Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. JOURNAL OF NANOBIOTECHNOLOGY, 21 (1): (1-21). [PMID:37858186] [10.1186/s12951-023-02146-0] |
| 14. Shan Gao, Wanlin Zhang, Xingxing Zhai, Xue Zhao, Jianxin Wang, Jie Weng, Jianshu Li, Xingyu Chen. (2023) An antibacterial and proangiogenic double-layer drug-loaded microneedle patch for accelerating diabetic wound healing. Biomaterials Science, 11 (2): (533-541). [PMID:36472206] [10.1039/D2BM01588A] |
| 15. Kai Sun, Jiaying Yu, Jinzhong Hu, Jian Chen, Jia Song, Zhixin Chen, Zhuoer Cai, Zhuoxuan Lu, Liming Zhang, Zhifei Wang. (2022) Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment. Acta Biomaterialia, 148 (230). [PMID:35724919] [10.1016/j.actbio.2022.06.026] |
| 16. Xueyang Jin, Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Yue Liu, Wenqiang Chang, Hongxiang Lou. (2021) Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration. Journal of Advanced Research, 34 (65). [PMID:35024181] [10.1016/j.jare.2021.06.016] |
| 17. Fanjia Dai, Jiaying Zhang, Fengjiao Chen, Xianwu Chen, Celine Jessica Lee, Hongze Liang, Lingling Zhao, Hui Tan. (2024) A Multi-Responsive Hydrogel Combined With Mild Heat Stimulation Promotes Diabetic Wound Healing by Regulating Inflammatory and Enhancing Angiogenesis. Advanced Science, (2408783). [PMID:39435670] [10.1002/advs.202408783] |
| 18. Yupei Sun, Qin Lu, Die Dong, Rimei Chen, Zhiping Chen, Zhen Xie, Hongxiang Zhu, Qing Bu, Hui He, Shuangfei Wang. (2024) Engineering a monitoring-therapeutic in situ hydrogel via a cellulose-integrated nanointerface. CHEMICAL ENGINEERING JOURNAL, 482 (149015). [10.1016/j.cej.2024.149015] |
| 19. Wajiha Ahmed, Shifen Li, Min Liang, Yongyuan Kang, Xiaoqing Liu, Changyou Gao. (2024) Multifunctional Drug- and AuNRs-Loaded ROS-Responsive Selenium-Containing Polyurethane Nanofibers for Smart Wound Healing. ACS Biomaterials Science & Engineering, 10 (6): (3946-3957). [PMID:38701357] [10.1021/acsbiomaterials.4c00363] |
| 20. Weichen Sun, Xiaoting Zuo, Yu Zhang, Chengyan Zhou, Shuai Guo, Wenjuan Li, Mingtao Run, Jianglei Qin. (2024) Quaternary ammonium grafted chitosan hydrogel with enhanced antibacterial performance as tannin acid and deferoxamine carrier to promote diabetic wound healing. COLLOIDS AND SURFACES B-BIOINTERFACES, 244 (114160). [PMID:39142232] [10.1016/j.colsurfb.2024.114160] |